106 related articles for article (PubMed ID: 4094420)
1. 1,2-Diaryl-3,4-dihydronaphthalenes: photofluorogenic ligands for the estrogen receptor.
Bindal RD; Katzenellenbogen JA
J Steroid Biochem; 1985 Dec; 23(6A):929-37. PubMed ID: 4094420
[TBL] [Abstract][Full Text] [Related]
2. Torsionally and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands.
Anstead GM; Peterson CS; Pinney KG; Wilson SR; Katzenellenbogen JA
J Med Chem; 1990 Oct; 33(10):2726-34. PubMed ID: 2213825
[TBL] [Abstract][Full Text] [Related]
3. Facile synthesis of high affinity styrylpyridine systems as inherently fluorescent ligands for the estrogen receptor.
Meyers MJ; Carlson KE; Katzenellenbogen JA
Bioorg Med Chem Lett; 1998 Dec; 8(24):3589-94. PubMed ID: 9934476
[TBL] [Abstract][Full Text] [Related]
4. 2,3-Diarylindenes and 2,3-diarylindenones: synthesis, molecular structure, photochemistry, estrogen receptor binding affinity, and comparisons with related triarylethylenes.
Anstead GM; Altenbach RJ; Wilson SR; Katzenellenbogen JA
J Med Chem; 1988 Jul; 31(7):1316-26. PubMed ID: 3385728
[TBL] [Abstract][Full Text] [Related]
5. Desmethylnafoxidine aziridine: an electrophilic affinity label for the estrogen receptor with high efficiency and selectivity.
Simpson DM; Elliston JF; Katzenellenbogen JA
J Steroid Biochem; 1987 Sep; 28(3):233-45. PubMed ID: 3657146
[TBL] [Abstract][Full Text] [Related]
6. Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of receptor.
Hwang KJ; Carlson KE; Anstead GM; Katzenellenbogen JA
Biochemistry; 1992 Nov; 31(46):11536-45. PubMed ID: 1445887
[TBL] [Abstract][Full Text] [Related]
7. Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations.
Carlson KE; Coppey M; Magdelenat H; Katzenellenbogen JA
J Steroid Biochem; 1989 Mar; 32(3):345-55. PubMed ID: 2539536
[TBL] [Abstract][Full Text] [Related]
8. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
10. Preparation, receptor binding, and fluorescence properties of hexestrol-fluorophore conjugates: evaluation of site of attachment, fluorophore structure, and fluorophore-ligand spacing.
Fevig TL; Lloyd JE; Zablocki JA; Katzenellenbogen JA
J Med Chem; 1987 Jan; 30(1):156-65. PubMed ID: 3027331
[TBL] [Abstract][Full Text] [Related]
11. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
Evans E; Baskevitch PP; Rochefort H
Eur J Biochem; 1982 Nov; 128(1):185-91. PubMed ID: 7173202
[TBL] [Abstract][Full Text] [Related]
13. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
[TBL] [Abstract][Full Text] [Related]
14. Gap junction modulation in rat uterus. III. Structure-activity relationships of estrogen receptor-binding ligands on myometrial and serosal cells.
Burghardt RC; Gaddy-Kurten D; Burghardt RL; Kurten RC; Mitchell PA
Biol Reprod; 1987 Apr; 36(3):741-51. PubMed ID: 3593845
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (+/-)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxyl]-1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metabolite.
Tatee T; Carlson KE; Katzenellenbogen JA; Robertson DW; Katzenellenbogen BS
J Med Chem; 1979 Dec; 22(12):1509-17. PubMed ID: 536996
[TBL] [Abstract][Full Text] [Related]
16. Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor.
Kim SH; Katzenellenbogen JA
Bioorg Med Chem; 2000 Apr; 8(4):785-93. PubMed ID: 10819167
[TBL] [Abstract][Full Text] [Related]
17. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
Borgna JL; Rochefort H
Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
[TBL] [Abstract][Full Text] [Related]
18. Integrated "3+1" oxorhenium(V) complexes as estrogen mimics.
Skaddan MB; Katzenellenbogen JA
Bioconjug Chem; 1999; 10(1):119-29. PubMed ID: 9893973
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens.
Heiman DF; Senderoff SG; Katzenellenbogen JA; Neeley RJ
J Med Chem; 1980 Sep; 23(9):994-1002. PubMed ID: 7411555
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
Gulino A; Pasqualini JR
Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
